GI expertise growth Leverage Alimentiv's leadership in GI CRO services and strong presence in IBD trials to target pharma and biotech partners seeking specialized GI trial design, imaging, and biomarker capabilities for faster study activation and patient enrollment.

Global reach Capitalize on Alimentiv's extensive global site network (5,000+ sites in 60+ countries) to propose scalable, multi-regional trials with streamlined regulatory and operational support, appealing to sponsors aiming for broad patient access and faster timelines.

Data and AI edge Promote the AI scoring solution for ulcerative colitis and the Statistics Centre of Excellence to clients needing advanced data analytics, real-world evidence, and robust statistical rigor to de-risk development and differentiate trials.

Full-service value Highlight Alimentiv’s end-to-end offerings—from clinical trial services to histopathology, spatial biology, and real-world evidence—as a one-stop CRO to reduce vendor management, accelerate study milestones, and improve data harmonization.

Growth and visibility Target sponsors investing in expanding GI portfolios, given Alimentiv’s active conference presence and recent publications/posters at ECCO and UEG Week, signaling ongoing thought leadership and collaboration opportunities to co-develop innovative trial designs.